The Directors (together with their families and their family trusts and pension scheme and other arrangements) in aggregate hold 2,696,430 ordinary shares in the Company, representing 4.74% of the Company’s current issued share capital. 15.50% of the issued share capital is not in public hands. The Company has been made aware of the following significant (3% or greater) shareholdings in the Company’s ordinary shares:

Number of ordinary shares % of issued share capital
Obotritia Capital KGaA 10.76%
Richard Griffiths and Controlled Undertakings 7.15%
Octopus Investments Nominees Ltd 6.72%
Rosetta Capital VI GP LP, on behalf of Rosetta Capital VI, LP 5.66%
Arthurian Life Sciences SPV GP Ltd, as GP of The Wales Life Sciences Investment Fund LP 5.28%

The above information was last updated on Wednesday, 21 April 2021